We present the results of the RESPRO study, a Spanish multicenter retrospective analysis of salvage brachytherapy for locally recurrent prostate cancer, including 188 patients.
I am deeply grateful to all participating centers
Especially to David Büchser García and Elena Villafranca.
Day One of #PROSCA24
Presenter: Dr. Ken Herrmann
Case discussion session: High-risk localised/locally advanced PCa
TOPIC: Regional lymph node staging by PSMA-PET
https://buff.ly/4gaR6Kx
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
#WhereisHoskin guides us through the evidence for salvage #radiotherapy for #prostatecancer Some things are clear
➡️ Early salvage
➡️ No benefit of dose escalation
Others not
➡️ Duration of ADT
➡️ Impact of nodal RT
@oncoalert.bsky.social #PROSCA24
Day One of #PROSCA24
Dr. Thomas Zilli
High-risk localised/locally advanced #prostatecancer
TOPIC: Combination of radiotherapy and systemic treatment for high-risk patients
https://buff.ly/3Z6ivq6
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@yukselurun.bsky.social
@achoud72.bsky.social
Study design via @urotoday
#CAPItello-281 Phase III trial
www.urotoday.com/conference-h...
Hi! I want the be added
Excelente organización y nivel científico en las Jornadas de #Braquiterapia. Valladolid 2024.
El año que viene nos vemos en Pamplona.
#oncsky #brachytehrapy #radiotherapy #seor #sefm
